DIAGNOSTIC REPORT
MC-6469
PATIENT NAME : DR. SONALI SINGH REF. DOCTOR : SELF
CODE/NAME & ADDRESS : C000146245 ACCESSION NO : 0024XJ009720 AGE/SEX : 33 Years Female
MAMTA DIAGNOSTIC CENTRE PATIENT ID : DRSOF25109124 DRAWN : 25/10/2024 [Link]
PARMESHWAR COMPLEX MUNNA, KHERA,
CLIENT PATIENT ID: RECEIVED : 25/10/2024 [Link]
SADRAUNA ROAD PARA,LUCKNOW
ABHA NO : REPORTED : 25/10/2024 [Link]
LUCKNOW 226011
7651901938
Test Report Status Final Results Biological Reference Interval Units
HAEMATOLOGY - CBC
PERIPHERAL SMEAR EXAM, EDTA WHOLE BLOOD
RBC MILD ANISOCYTOSIS WITH MICROCYTIC HYPOCHROMIC RBCS.
WBC WBCS ARE NORMAL IN NUMBER & MORPHOLOGY
PLATELETS PLATELETS ARE ADEQUATE IN NUMBER
IMPRESSION MICROCYTIC HYPOCHROMIC BLOOD PICTURE
DENGUE FEVER(NS1 ANTIGEN,IGG,IGM RAPID & CBC)
BLOOD COUNTS, EDTA WHOLE BLOOD
HEMOGLOBIN (HB) 12.7 12.0 - 15.0 g/dL
METHOD : SPECTROPHOTOMETRY
RED BLOOD CELL (RBC) COUNT 5.72 High 3.8 - 4.8 mil/µL
METHOD : ELECTRICAL IMPEDANCE
WHITE BLOOD CELL (WBC) COUNT 6.9 4.0 - 10.0 thou/µL
METHOD : ELECTRICAL IMPEDANCE
PLATELET COUNT 168 150 - 410 thou/µL
METHOD : ELECTRICAL IMPEDANCE/MICROSCOPY
RBC AND PLATELET INDICES
HEMATOCRIT (PCV) 41.0 36 - 46 %
METHOD : ELECTRONIC IMPEDANCE/CALCULATION
MEAN CORPUSCULAR VOLUME (MCV) 72.0 Low 83 - 101 fL
METHOD : CALCULATED PARAMETER
MEAN CORPUSCULAR HEMOGLOBIN (MCH) 22.3 Low 27.0 - 32.0 pg
METHOD : CALCULATED PARAMETER
MEAN CORPUSCULAR HEMOGLOBIN 31.1 Low 31.5 - 34.5 g/dL
CONCENTRATION(MCHC)
METHOD : CALCULATED PARAMETER
RED CELL DISTRIBUTION WIDTH (RDW) 14.2 High 11.6 - 14.0 %
METHOD : CALCULATED PARAMETER
MEAN PLATELET VOLUME (MPV) 12.3 High 6.8 - 10.9 fL
METHOD : CALCULATED PARAMETER
Page 1 Of 8
[Link] Tiwari, MBBS, DNB
(Pathology),([Link]. UPMC -
58080)
Lab Head
View Details View Report
PERFORMED AT :
Agilus Diagnostics Ltd
C-3/282,Vipul Khand, Gomtinagar
Lucknow, 226010 ULR No.775000009825926-0024
Uttar Pradesh, India
Tel : 9111591115, Fax : 0522 - 406 2980
CIN - U74899PB1995PLC045956
Email : [Link]@[Link]
DIAGNOSTIC REPORT
MC-6469
PATIENT NAME : DR. SONALI SINGH REF. DOCTOR : SELF
CODE/NAME & ADDRESS : C000146245 ACCESSION NO : 0024XJ009720 AGE/SEX : 33 Years Female
MAMTA DIAGNOSTIC CENTRE PATIENT ID : DRSOF25109124 DRAWN : 25/10/2024 [Link]
PARMESHWAR COMPLEX MUNNA, KHERA,
CLIENT PATIENT ID: RECEIVED : 25/10/2024 [Link]
SADRAUNA ROAD PARA,LUCKNOW
ABHA NO : REPORTED : 25/10/2024 [Link]
LUCKNOW 226011
7651901938
Test Report Status Final Results Biological Reference Interval Units
WBC DIFFERENTIAL COUNT
NEUTROPHILS 53 40 - 80 %
METHOD : MICROSCOPY /IMPEDANCE
LYMPHOCYTES 38 20 - 40 %
METHOD : MICROSCOPY /IMPEDANCE
MONOCYTES 04 2 - 10 %
METHOD : IMPEDANCE / MICROSCOPY
EOSINOPHILS 05 1-6 %
METHOD : IMPEDANCE / MICROSCOPY
BASOPHILS 00 0-2 %
METHOD : IMPEDANCE / MICROSCOPY
ABSOLUTE NEUTROPHIL COUNT 3.66 2.0 - 7.0 thou/µL
METHOD : CALCULATED PARAMETER
ABSOLUTE LYMPHOCYTE COUNT 2.62 1.0 - 3.0 thou/µL
METHOD : CALCULATED PARAMETER
ABSOLUTE MONOCYTE COUNT 0.28 0.2 - 1.0 thou/µL
METHOD : CALCULATED PARAMETER
ABSOLUTE EOSINOPHIL COUNT 0.34 0.02 - 0.50 thou/µL
METHOD : CALCULATED PARAMETER
ERYTHROCYTE SEDIMENTATION RATE (ESR),EDTA BLOOD
E.S.R 06 0 - 20 mm at 1 hr
METHOD : WESTERGREN METHOD
Interpretation(s)
RBC AND PLATELET INDICES-Mentzer index (MCV/RBC) is an automated cell-counter based calculated screen tool to differentiate cases of Iron deficiency anaemia(>13)
from Beta thalassaemia trait (<13) in patients with microcytic anaemia. This needs to be interpreted in line with clinical correlation and suspicion. Estimation of HbA2
remains the gold standard for diagnosing a case of beta thalassaemia trait.
WBC DIFFERENTIAL COUNT-The optimal threshold of 3.3 for NLR showed a prognostic possibility of clinical symptoms to change from mild to severe in COVID positive
patients. When age = 49.5 years old and NLR = 3.3, 46.1% COVID-19 patients with mild disease might become severe. By contrast, when age < 49.5 years old and NLR <
3.3, COVID-19 patients tend to show mild disease. (Reference to - The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients A.-P. Yang, et al.
International Immunopharmacology 84 (2020) 106504
This ratio element is a calculated parameter and out of NABL scope.
ERYTHROCYTE SEDIMENTATION RATE (ESR),EDTA BLOOD-TEST DESCRIPTION :- Erythrocyte sedimentation rate (ESR) is a test that indirectly measures the degree of
inflammation present in the body. The test actually measures the rate of fall (sedimentation) of erythrocytes in a sample of blood that has been placed into a tall, thin,
Page 2 Of 8
[Link] Tiwari, MBBS, DNB
(Pathology),([Link]. UPMC -
58080)
Lab Head
View Details View Report
PERFORMED AT :
Agilus Diagnostics Ltd
C-3/282,Vipul Khand, Gomtinagar
Lucknow, 226010 ULR No.775000009825926-0024
Uttar Pradesh, India
Tel : 9111591115, Fax : 0522 - 406 2980
CIN - U74899PB1995PLC045956
Email : [Link]@[Link]
DIAGNOSTIC REPORT
MC-6469
PATIENT NAME : DR. SONALI SINGH REF. DOCTOR : SELF
CODE/NAME & ADDRESS : C000146245 ACCESSION NO : 0024XJ009720 AGE/SEX : 33 Years Female
MAMTA DIAGNOSTIC CENTRE PATIENT ID : DRSOF25109124 DRAWN : 25/10/2024 [Link]
PARMESHWAR COMPLEX MUNNA, KHERA,
CLIENT PATIENT ID: RECEIVED : 25/10/2024 [Link]
SADRAUNA ROAD PARA,LUCKNOW
ABHA NO : REPORTED : 25/10/2024 [Link]
LUCKNOW 226011
7651901938
Test Report Status Final Results Biological Reference Interval Units
vertical tube. Results are reported as the millimetres of clear fluid (plasma) that are present at the top portion of the tube after one hour. Nowadays fully automated
instruments are available to measure ESR.
- ESR is not diagnostic it is a non-specific test that may be elevated in a number of different conditions. It provides general information about the presence of an
inflammatory [Link] is superior to ESR because it is more sensitive and reflects a more rapid change.
TEST INTERPRETATION : Increase in: Infections, Vasculities, Inflammatory arthritis, Renal disease, Anemia, Malignancies and plasma cell dyscrasias, Acute allergy
Tissue injury, Pregnancy, Estrogen medication, Aging.
Finding a very accelerated ESR(>100 mm/hour) in patients with ill-defined symptoms directs the physician to search for a systemic disease (Paraproteinemias,
Disseminated malignancies, connective tissue disease, severe infections such as bacterial endocarditis).
In pregnancy BRI in first trimester is 0-48 mm/hr(62 if anemic) and in second trimester (0-70 mm /hr(95 if anemic). ESR returns to normal 4th week post partum.
Decreased in: Polycythermia vera, Sickle cell anemia
LIMITATIONS : False elevated ESR : Increased fibrinogen, Drugs(Vitamin A, Dextran etc), Hypercholesterolemia
False Decreased : Poikilocytosis,(SickleCells,spherocytes),Microcytosis, Low fibrinogen, Very high WBC counts, Drugs(Quinine, salicylates)
REFERENCE : Nathan and Oski’s Haematology of Infancy and Childhood, 5th edition 2. Paediatric reference intervals. AACC Press, 7th edition. Edited by S. Soldin 3. The
reference for the adult reference range is “Practical Haematology by Dacie and Lewis,10th edition.
Page 3 Of 8
[Link] Tiwari, MBBS, DNB
(Pathology),([Link]. UPMC -
58080)
Lab Head
View Details View Report
PERFORMED AT :
Agilus Diagnostics Ltd
C-3/282,Vipul Khand, Gomtinagar
Lucknow, 226010 ULR No.775000009825926-0024
Uttar Pradesh, India
Tel : 9111591115, Fax : 0522 - 406 2980
CIN - U74899PB1995PLC045956
Email : [Link]@[Link]
DIAGNOSTIC REPORT
MC-6469
PATIENT NAME : DR. SONALI SINGH REF. DOCTOR : SELF
CODE/NAME & ADDRESS : C000146245 ACCESSION NO : 0024XJ009720 AGE/SEX : 33 Years Female
MAMTA DIAGNOSTIC CENTRE PATIENT ID : DRSOF25109124 DRAWN : 25/10/2024 [Link]
PARMESHWAR COMPLEX MUNNA, KHERA,
CLIENT PATIENT ID: RECEIVED : 25/10/2024 [Link]
SADRAUNA ROAD PARA,LUCKNOW
ABHA NO : REPORTED : 25/10/2024 [Link]
LUCKNOW 226011
7651901938
Test Report Status Final Results Biological Reference Interval Units
SEROLOGY
RAPID TYPHI IGM, SERUM/PLASMA EDTA/EDTA WB
RAPID TYPHI IGM NOT DETECTED NOT DETECTED
METHOD : IMMUNOCHROMATOGRAPHY
DENGUE FEVER(NS1 ANTIGEN,IGG,IGM RAPID & CBC)
DENGUE DUO(NS1 ANTIGEN ,IGG & IGM ANTIBODY),
RAPID
DENGUE NS1 ANTIGEN NEGATIVE NEGATIVE
METHOD : IMMUNOCHROMATOGRAPHY
DENGUE IGG ANTIBODIES NEGATIVE NEGATIVE
METHOD : IMMUNOCHROMATOGRAPHY
DENGUE IGM ANTIBODIES NEGATIVE NEGATIVE
METHOD : IMMUNOCHROMATOGRAPHY
Comments
THIS REPORT IS BASED ON SCREENING TEST AND IS PROVISIONAL. THE PRESENCE OF DENGUE ANTIGEN AND ANTIBODIES SHOULD BE
CONFIRMED BY MAC ELISA.
Interpretation(s)
RAPID TYPHI IGM, SERUM/PLASMA EDTA/EDTA WB-RAPID TYPHI IgM
Typhoid fever is a bacterial infection caused by Salmonella serotypes including [Link], [Link] A, S. paratyphi B and Salmonella sendai. The symptoms of the illness
include high fever, headache, abdominal pain, constipation and appearance of skin rashes. Accurate diagnosis of typhoid fever at an early stage is not only important for
etiological diagnosis but to identify and treat the potential carriers and prevent acute typhoid fever outbreaks. The conventional WIDAL test usually detects antibodies to
[Link] in the patient serum from the second week of onset of the symptoms. Early rising antibodies to Lypopolysaccharides (LPS) O are predominantly IgM in nature.
Test Utility:
Detection of [Link] specific IgM antibodies instead of IgG or both IgG and IgM (as measured by Widal test) serve as a rapid marker for recent infection.
Limitations:
A negative result does not rule out recent of current infection, as the positivity is influenced by the time elapsed from the onset of fever and immunocompetence of the
patient. However, if [Link] infection is still suspected, retesting with second specimen obtained 5-7 days later is recommended.
DENGUE DUO(NS1 ANTIGEN ,IGG & IGM ANTIBODY), RAPID-Dengue virus is transmitted by Aedes mosquitoes. It belongs to the genus Flavivirus and has four serotypes,
DEN-1, DEN-2, DEN-3, and DEN-4. Infection with one dengue serotype provides lifelong immunity to that virus, but no cross protective immunity to the other serotypes.
Human dengue infection causes a spectrum of illnesses ranging from inapparent or mild febrile illness to severe to fatal hemorrhagic disease. WHO classifies dengue
infections as primary or secondary. It is believed that patients experiencing a secondary infection with heterologous serotypes have higher risk of complications, including
Dengue Haemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS).
Test Utility:
Dengue NS1 antigen can be detected in serum from day 1 after onset of clinical signs, up to day 9. Dengue specific IgM can be detected as early as 5 days after the onset of
Page 4 Of 8
Dr. Richa Tripathi, MBBS, MD
(Microbiology)
Consultant Microbiologist
View Details View Report
PERFORMED AT :
Agilus Diagnostics Ltd
C-3/282,Vipul Khand, Gomtinagar
Lucknow, 226010 ULR No.775000009825926-0024
Uttar Pradesh, India
Tel : 9111591115, Fax : 0522 - 406 2980
CIN - U74899PB1995PLC045956
Email : [Link]@[Link]
DIAGNOSTIC REPORT
MC-6469
PATIENT NAME : DR. SONALI SINGH REF. DOCTOR : SELF
CODE/NAME & ADDRESS : C000146245 ACCESSION NO : 0024XJ009720 AGE/SEX : 33 Years Female
MAMTA DIAGNOSTIC CENTRE PATIENT ID : DRSOF25109124 DRAWN : 25/10/2024 [Link]
PARMESHWAR COMPLEX MUNNA, KHERA,
CLIENT PATIENT ID: RECEIVED : 25/10/2024 [Link]
SADRAUNA ROAD PARA,LUCKNOW
ABHA NO : REPORTED : 25/10/2024 [Link]
LUCKNOW 226011
7651901938
Test Report Status Final Results Biological Reference Interval Units
fever and generally persists for 30-90 days, although detectable levels may be present rarely upto 8 months post-infection. IgM antibody is also produced in secondary and
tertiary dengue infections, although the response in some secondary and probably most tertiary infections is low level and transient. Dengue IgG levels usually start rising at
the end of 1st week in primary infection and persists for months and sometimes for life. Patients with primary dengue infections usually are IgM positive & IgG negative with
higher IgM concentrations, whereas patients with secondary infections are usually both IgG and IgM positive with higher IgG concentrations.
Confirmed diagnosis of Dengue fever can be established in a suspected case with atleast one of the following tests:
1) Demonstration of NS1 antigen by ELISA
2) Demonstration of IgM antibody titre by ELISA in single serum sample,
3) IgG seroconversion in paired sera after 2 weeks with 4 fold rise in titre
4) Demonstration of viral nucleic acid by PCR
Limitations:
• A negative result may occur if the quantity of antigen/antibody present in the specimen is below the detection limit of the assay, or the antibodies are not present during
the stage of disease when the specimen is collected.
• Patients suffering from other flavivirus infections (Tick-borne encephalitis virus, Japanese encephalitis virus etc) may give a false positive dengue test due to presence of
cross reactive epitopes. Hence all results should be interpreted in conjunction with clinical findings and patient history.
• Due to sensitivity & specificity concerns, positive NS1 antigen/IgM results obtained with rapid dengue tests(RDT) are only provisional and point to “PROBABLE DENGUE”
infection . For confirmatory dengue diagnosis, GOI notification 2016 mandates to test RDT positive specimens with ELISA.
Page 5 Of 8
Dr. Richa Tripathi, MBBS, MD
(Microbiology)
Consultant Microbiologist
View Details View Report
PERFORMED AT :
Agilus Diagnostics Ltd
C-3/282,Vipul Khand, Gomtinagar
Lucknow, 226010 ULR No.775000009825926-0024
Uttar Pradesh, India
Tel : 9111591115, Fax : 0522 - 406 2980
CIN - U74899PB1995PLC045956
Email : [Link]@[Link]
DIAGNOSTIC REPORT
MC-6469
PATIENT NAME : DR. SONALI SINGH REF. DOCTOR : SELF
CODE/NAME & ADDRESS : C000146245 ACCESSION NO : 0024XJ009720 AGE/SEX : 33 Years Female
MAMTA DIAGNOSTIC CENTRE PATIENT ID : DRSOF25109124 DRAWN : 25/10/2024 [Link]
PARMESHWAR COMPLEX MUNNA, KHERA,
CLIENT PATIENT ID: RECEIVED : 25/10/2024 [Link]
SADRAUNA ROAD PARA,LUCKNOW
ABHA NO : REPORTED : 25/10/2024 [Link]
LUCKNOW 226011
7651901938
Test Report Status Final Results Biological Reference Interval Units
SPECIALISED CHEMISTRY - HORMONE
THYROID PANEL, SERUM
T3 158.20 80.00 - 200.00 ng/dL
METHOD : ELECTROCHEMILUMINESCENCE IMMUNO ASSAY
T4 9.48 5.10 - 14.10 µg/dL
METHOD : ELECTROCHEMILUMINESCENCE IMMUNO ASSAY
TSH (ULTRASENSITIVE) 3.220 Non Pregnant Women µIU/mL
0.27 - 4.20
Pregnant Women (As per
American Thyroid Association)
1st Trimester 0.100 - 2.500
2nd Trimester 0.200 - 3.000
3rd Trimester 0.300 - 3.000
METHOD : ELECTROCHEMILUMINESCENCE IMMUNO ASSAY
Interpretation(s)
Page 6 Of 8
[Link] Tiwari, MBBS, DNB
(Pathology),([Link]. UPMC -
58080)
Lab Head
View Details View Report
PERFORMED AT :
Agilus Diagnostics Ltd
C-3/282,Vipul Khand, Gomtinagar
Lucknow, 226010 ULR No.775000009825926-0024
Uttar Pradesh, India
Tel : 9111591115, Fax : 0522 - 406 2980
CIN - U74899PB1995PLC045956
Email : [Link]@[Link]
DIAGNOSTIC REPORT
MC-6469
PATIENT NAME : DR. SONALI SINGH REF. DOCTOR : SELF
CODE/NAME & ADDRESS : C000146245 ACCESSION NO : 0024XJ009720 AGE/SEX : 33 Years Female
MAMTA DIAGNOSTIC CENTRE PATIENT ID : DRSOF25109124 DRAWN : 25/10/2024 [Link]
PARMESHWAR COMPLEX MUNNA, KHERA,
CLIENT PATIENT ID: RECEIVED : 25/10/2024 [Link]
SADRAUNA ROAD PARA,LUCKNOW
ABHA NO : REPORTED : 25/10/2024 [Link]
LUCKNOW 226011
7651901938
Test Report Status Final Results Biological Reference Interval Units
**End Of Report**
Please visit [Link] for related Test Information for this accession
Page 7 Of 8
[Link] Tiwari, MBBS, DNB
(Pathology),([Link]. UPMC -
58080)
Lab Head
View Details View Report
PERFORMED AT :
Agilus Diagnostics Ltd
C-3/282,Vipul Khand, Gomtinagar
Lucknow, 226010 ULR No.775000009825926-0024
Uttar Pradesh, India
Tel : 9111591115, Fax : 0522 - 406 2980
CIN - U74899PB1995PLC045956
Email : [Link]@[Link]
DIAGNOSTIC REPORT
MC-6469
PATIENT NAME : DR. SONALI SINGH REF. DOCTOR : SELF
CODE/NAME & ADDRESS : C000146245 ACCESSION NO : 0024XJ009720 AGE/SEX : 33 Years Female
MAMTA DIAGNOSTIC CENTRE PATIENT ID : DRSOF25109124 DRAWN : 25/10/2024 [Link]
PARMESHWAR COMPLEX MUNNA, KHERA,
CLIENT PATIENT ID: RECEIVED : 25/10/2024 [Link]
SADRAUNA ROAD PARA,LUCKNOW
ABHA NO : REPORTED : 25/10/2024 [Link]
LUCKNOW 226011
7651901938
Test Report Status Final Results Biological Reference Interval Units
CONDITIONS OF LABORATORY TESTING & REPORTING
1. It is presumed that the test sample belongs to the patient 5. AGILUS Diagnostics confirms that all tests have been
named or identified in the test requisition form. performed or assayed with highest quality standards, clinical
2. All tests are performed and reported as per the safety & technical integrity.
turnaround time stated in the AGILUS Directory of Services. 6. Laboratory results should not be interpreted in isolation;
3. Result delays could occur due to unforeseen it must be correlated with clinical information and be
circumstances such as non-availability of kits / equipment interpreted by registered medical practitioners only to
breakdown / natural calamities / technical downtime or any determine final diagnosis.
other unforeseen event. 7. Test results may vary based on time of collection,
4. A requested test might not be performed if: physiological condition of the patient, current medication or
i. Specimen received is insufficient or inappropriate nutritional and dietary changes. Please consult your doctor
ii. Specimen quality is unsatisfactory or call us for any clarification.
iii. Incorrect specimen type 8. Test results cannot be used for Medico legal purposes.
iv. Discrepancy between identification on specimen 9. In case of queries please call customer care
container label and test requisition form (91115 91115) within 48 hours of the report.
.
Agilus Diagnostics Ltd
Fortis Hospital, Sector 62, Phase VIII,
Mohali 160062
Page 8 Of 8
[Link] Tiwari, MBBS, DNB
(Pathology),([Link]. UPMC -
58080)
Lab Head
View Details View Report
PERFORMED AT :
Agilus Diagnostics Ltd
C-3/282,Vipul Khand, Gomtinagar
Lucknow, 226010 ULR No.775000009825926-0024
Uttar Pradesh, India
Tel : 9111591115, Fax : 0522 - 406 2980
CIN - U74899PB1995PLC045956
Email : [Link]@[Link]
